Revision of Annex 16: Results of Public Consultation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The responses to the public consultation on the revision of Annex 16 (Certification by a Qualified Person and Batch Release) have been published.
Amongst other Organisations like the Austrian QP Association, the European QP Association (EQPA) also gave feedback to the draft annex 16. The EQPA highly appreciates the on-going revision of Annex 16 to the EU GMP Guide, reflecting the current changes in the pharmaceutical environment, including the globalisation of supply chains as well as new quality control strategies.
The Association also welcomes the further steps to harmonization of requirements in the Member States, by clarifying which have to be performed by a Qualified Person (QP) personally and those that can be delegated. This includes the reliance on company or site - based quality systems, as described in Chapter 1 of the EU GMP Guide part I. The EQPA also expressed some concerns regarding the implementation in practice for some provisions and made some proposals reading terminology.
The responses can be found on the European Commission website.
Related GMP News
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
19.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?